BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$480M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$291M |
| 3 |
DuPont de Nemours
DD
|
+$220M |
| 4 |
Pinduoduo
PDD
|
+$214M |
| 5 |
PepsiCo
PEP
|
+$209M |
Top Sells
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$279B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$955M |
| 3 |
Microsoft
MSFT
|
+$474M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$339M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$298M |
Sector Composition
| 1 | Technology | 17.21% |
| 2 | Healthcare | 11.8% |
| 3 | Consumer Discretionary | 10.72% |
| 4 | Financials | 10.28% |
| 5 | Industrials | 7.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1576
BioXcel Therapeutics
BTAI
$49.8M
| $760K | ﹤0.01% |
2,211
-1,162
| -34% | -$399K |
|
1577
CarGurus
CARG
$3.58B
| $758K | ﹤0.01% |
54,117
+2,579
| +5% | +$36.1K |
|
1578
Clarus
CLAR
$147M
| $758K | ﹤0.01% |
96,651
-714,368
| -88% | -$5.6M |
|
|
UNIT
1579
Uniti Group
UNIT
$1.71B
| $757K | ﹤0.01% |
136,876
-65,029
| -32% | -$360K |
|
1580
Myriad Genetics
MYGN
$674M
| $757K | ﹤0.01% |
52,163
-53,953
| -51% | -$783K |
|
1581
IPG Photonics
IPGP
$3.38B
| $753K | ﹤0.01% |
7,951
-29,074
| -79% | -$2.75M |
|
|
GTY
1582
Getty Realty Corp
GTY
$1.6B
| $752K | ﹤0.01% |
22,216
-2,352
| -10% | -$79.6K |
|
1583
Live Oak Bancshares
LOB
$1.67B
| $752K | ﹤0.01% |
24,898
+4,940
| +25% | +$149K |
|
|
OTLY
1584
Oatly Group
OTLY
$544M
| $751K | ﹤0.01% |
21,594
+1,856
| +9% | +$64.6K |
|
1585
Enpro
NPO
$4.64B
| $747K | ﹤0.01% |
6,875
-4,340
| -39% | -$472K |
|
|
B
1586
DELISTED
Barnes Group Inc.
B
| $746K | ﹤0.01% |
18,268
-20,340
| -53% | -$831K |
|
1587
AdvanSix
ASIX
$576M
| $742K | ﹤0.01% |
19,514
+5,649
| +41% | +$215K |
|
1588
Prestige Consumer Healthcare
PBH
$3.11B
| $741K | ﹤0.01% |
11,835
-12,455
| -51% | -$780K |
|
1589
United Natural Foods
UNFI
$1.77B
| $741K | ﹤0.01% |
19,138
-10,087
| -35% | -$390K |
|
1590
Stepan Co
SCL
$1.09B
| $741K | ﹤0.01% |
6,957
-4,396
| -39% | -$468K |
|
1591
Antero Midstream
AM
$8.91B
| $738K | ﹤0.01% |
68,437
-44,205
| -39% | -$477K |
|
1592
Varex Imaging
VREX
$469M
| $738K | ﹤0.01% |
+36,375
| New | +$738K |
|
1593
Axsome Therapeutics
AXSM
$5.91B
| $736K | ﹤0.01% |
9,543
-6,193
| -39% | -$478K |
|
1594
Trinity Industries
TRN
$2.28B
| $734K | ﹤0.01% |
24,821
-14,657
| -37% | -$433K |
|
1595
Herc Holdings
HRI
$4.2B
| $733K | ﹤0.01% |
5,570
-9,072
| -62% | -$1.19M |
|
|
EGRX
1596
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $732K | ﹤0.01% |
25,050
+1,754
| +8% | +$51.3K |
|
1597
iShares MSCI World ETF
URTH
$5.72B
| $732K | ﹤0.01% |
+6,700
| New | +$732K |
|
|
IAA
1598
DELISTED
IAA, Inc. Common Stock
IAA
| $732K | ﹤0.01% |
18,297
+14,044
| +330% | +$562K |
|
1599
Tanger
SKT
$3.86B
| $731K | ﹤0.01% |
40,745
-26,435
| -39% | -$474K |
|
1600
PDF Solutions
PDFS
$765M
| $728K | ﹤0.01% |
25,525
-10,578
| -29% | -$302K |
|